Document is current
Any future updates will be listed below
-
Authors
Mello, Eleonora
Sorrentino, Stefano
Bucciarelli, Alessio
Cordelli, Ermanno
De Luca, Elisa
Nygaard, Haakon
Wendt, Stefan
Rainer, Alberto
Gigli, Giuseppe
Moroni, Lorenzo
Polini, Alessandro
Mozetic, Pamela
-
Funding
Funding for this research was provided by:
Ministero della Salute (Operational Health Plan, Trajectory 4, ID T4-AN-09 (CAL.HUB.RIA), “Polo High Tech Lecce” Health Operational Plan - Development and Cohesion Fund 2014-2020, Trajectory 4 (grant nr. T4-AN-01, OS2, CUP: F83C22001560003).)
European Union - Next Generation EU- NRRP M4.C2- Investment 1.4 ("National Center for Gene Therapy and Drug based on RNA Technology" (CN00000041 CN3 RNA), "National Center for Gene Therapy and Drug based on RNA Technology" (CN00000041 CN3 RNA), "National Center for Gene Therapy and Drug based on RNA Technology" (CN00000041 CN3 RNA))
Regione Puglia (Tecnopolo per la medicina di precisione" CUP: B84I18000540002 (TecnoMed Puglia)-, Tecnopolo per la medicina di precisione" CUP: B84I18000540002 (TecnoMed Puglia)-, Tecnopolo per la medicina di precisione" CUP: B84I18000540002 (TecnoMed Puglia)-, Tecnopolo per la medicina di precisione" CUP: B84I18000540002 (TecnoMed Puglia)-, Tecnopolo per la medicina di precisione" CUP: B84I18000540002 (TecnoMed Puglia)-, Tecnopolo per la medicina di precisione" CUP: B84I18000540002 (TecnoMed Puglia)-, Tecnopolo per la medicina di precisione" CUP: B84I18000540002 (TecnoMed Puglia)-)
Ministero dell'Università e della Ricerca (PNC0000007-“Fit4MedRob - Fit for Medical Robotics” Grant, PNC0000007-“Fit4MedRob - Fit for Medical Robotics” Grant, PNC0000007-“Fit4MedRob - Fit for Medical Robotics” Grant, PNC0000007-“Fit4MedRob - Fit for Medical Robotics” Grant)
- License Information
-
More Information
Article History
Received: 1 August 2024
Accepted: 18 July 2025
First Online: 31 July 2025
Declarations
:
: The WTSli095-A iPS cell line, available at EBiSC, has been generated by the Wellcome Sanger Institute under the framework of the project “Human Induced Pluripotent Stem Cell Initiative - HIPSCI” funded by the Wellcome Trust and Medical Research Council and approved by the NRES Committee Yorkshire and the Humber– Leeds West (approval 15/YH/0391 dated 11 Aug 2015). The present research has received positive review by the local ethical committee (CNR Research Ethics and Integrity Committee, approval #0323823 17/09/2024).
: Not applicable.
: The authors declare there is no competing interest.
